At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The Christ Hospital ...
At the 2025 Transcatheter Cardiovascular Therapeutics® Conference, Dr. Jarrod Frizzell of The Christ Hospital presented ...
Guardant Health, Inc. , a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing in ...
Cordis, a global leader in interventional cardiovascular technology, today announced the groundbreaking results from the SELUTION DeNovo and SELUTION4ISR trials at Transcatheter Cardiovascular ...